SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-011938
Filing Date
2023-04-12
Accepted
2023-04-12 08:00:13
Documents
6
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 615943
2 formdef14a_001.jpg GRAPHIC 11258
3 formdef14a_002.jpg GRAPHIC 67657
4 formdef14a_003.jpg GRAPHIC 65385
5 proxy_001.jpg GRAPHIC 158437
6 proxy_002.jpg GRAPHIC 198951
  Complete submission text file 0001493152-23-011938.txt   1308532
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40652 | Film No.: 23814646
SIC: 2834 Pharmaceutical Preparations